Search for: "Merck, Sharpe "
Results 121 - 140
of 262
Sort by Relevance
|
Sort by Date
2 Nov 2017, 2:25 pm
” Circuit Judge Pauline Newman filed a dissenting opinion (Merck Sharp & Dohme Corp. v. [read post]
30 Oct 2017, 9:49 pm
(and Judge Pauline Newman continues to disagree with her brethren in some regards) in a decision handed down last Friday, in Merck Sharp & Dohme Corp. v. [read post]
22 Oct 2017, 9:59 pm
By Kevin E. [read post]
25 Aug 2017, 3:00 am
Merck Sharp & Dohme, 796 F.3d 1038 (9th Cir. 2015). [read post]
2 Apr 2017, 9:55 pm
Merck Sharp & Dohme Corp. v. [read post]
6 Jan 2017, 2:01 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in… [read post]
30 Dec 2016, 2:58 pm
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in… [read post]
22 Dec 2016, 8:35 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in… [read post]
16 Dec 2016, 4:44 am
| Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co Limited | Book review: Copyright and E-Learning | Friday Fantasies | Fontem see their patent “vaporised” – the dangers of added matter | BREAKING: Antidote found for poisonous priorities | Around the IP blogs | AIPPI Congress Report 5: Antitrust and Pharma - seeking a balance | When the Rolling Stones visited 2120 South Michigan Avenue in Chicago | No measure of success in… [read post]
9 Dec 2016, 1:00 pm
Eleonora Rosati discusses the VAT Directive comprising the equal treatment for both printed and electronic publications and its implications on digital exhaustion matters.Negative decision for anti-HIV therapy patent: Merck Sharpe & Dohme v Shionogi Co LimitedGuest Kat Eibhlin Vardy recaps Merck Sharp and Dohme Limited v Shionongi & Co Limited, [2016] EWHC 2989 (Pat), involving the alleged infringement of Shionogi’s European Patent, entitled… [read post]
2 Dec 2016, 3:30 am
Last week saw another Michaelmas decision from Mr Justice Arnold in the Patents Court in the form of Merck Sharpe and Dohme Limited v Shionogi & Co Limited [2016] EWHC 2989 (Pat). [read post]
19 Nov 2016, 4:48 am
Robinson in Merck Sharp & Dohme Corp. v. [read post]
31 Oct 2016, 6:09 am
Johnson & Johnson-Merck Consumer Pharm. [read post]
4 Oct 2016, 1:56 pm
Here is a list of direct-acting antivirals currently available in the US: Daklinza (daclatasvir) -- Bristol-Myers SquibbEpclusa (sofosbuvir and velpatasvir) -- Gilead SciencesHarvoni (ledipasvir and sofosbuvir) -- Gilead SciencesOlysio (simeprevir) -- JanssenSovaldi (sofosbuvir) -- Gilead SciencesTechnivie (ombitasvir and paritaprevir and ritonavir) -- AbbvieViekira Pak (dasabuvir and ombitasvir and paritaprevir and ritonavir) -- AbbvieViekira Pak XR (dasabuvir and ombitasvir and paritaprevir and… [read post]
29 Jul 2016, 1:30 pm
This term has been no different, but my, how they have ended in a dramatic fashion with....drum roll please...a reference to the CJEU from Mr Justice Arnold on the SPC Regulation in Merck Sharp & Dohme v Comptroller-General of Patents [2016] EWHC 1896.The problem and the questions to be referred What do you do if your patent is about to expire, but despite notice that Member States have agreed to grant your marketing authorization (MA) under the decentralized… [read post]
30 May 2016, 6:34 pm
Merck, Sharp & Dohme Corp. v. [read post]
17 May 2016, 10:11 am
This moggy will be speaking about enablement and sufficiency, in particular looking at the "plausibility" criterion that has become increasingly prominent in recent UK cases, for example Generics v Warner Lambert and Merck Sharp & Dohme v Ono Pharmaceutical. [read post]
13 May 2016, 4:12 am
€ 190 The post Sweden: Merck Sharp & Dohme v. [read post]
10 Apr 2016, 1:47 am
However, many cases fall somewhere between these two extremes, with an opposition being only partly successful, and/or the Hearing Officer finding that successful grounds of opposition might nonetheless be overcome by some form of amendment to the patent specification and claims.An example of this last type of outcome is the subject of a recent decision of the Federal Court of Australia in Merck Sharpe & Dohme (Australia) Pty Ltd v Genentech Inc [2016] FCA 324, which… [read post]
25 Mar 2016, 2:11 pm
The Dutch court's reasoning in the parallel case was consistent with the English Court (save they actually granted the relief sought, whereas Kitchin J held that the case for the declaration was arguable) (see Merck Sharpe & Dohme Manufacturing v Ratiopharm Nederland BV and others - February 13 2008 case number/docket number 288241/ HA ZA 07-1689).A new mantra for those clearing the path? [read post]
